These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 8584653

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG, Baker GB.
    J Affect Disord; 1995 Dec 13; 35(3):125-9. PubMed ID: 8749840
    [Abstract] [Full Text] [Related]

  • 4. Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.
    MacKenzie EM, Grant SL, Baker GB, Wood PL.
    Neurochem Res; 2008 Mar 13; 33(3):430-6. PubMed ID: 17768678
    [Abstract] [Full Text] [Related]

  • 5. Time-dependent changes in brain monoamine oxidase activity and in brain levels of monoamines and amino acids following acute administration of the antidepressant/antipanic drug phenelzine.
    Parent MB, Habib MK, Baker GB.
    Biochem Pharmacol; 2000 May 15; 59(10):1253-63. PubMed ID: 10736426
    [Abstract] [Full Text] [Related]

  • 6. Effects of the antidepressant/antipanic drug phenelzine on GABA concentrations and GABA-transaminase activity in rat brain.
    McManus DJ, Baker GB, Martin IL, Greenshaw AJ, McKenna KF.
    Biochem Pharmacol; 1992 Jun 09; 43(11):2486-9. PubMed ID: 1610412
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Task-dependent effects of the antidepressant/antipanic drug phenelzine on memory.
    Parent MB, Habib MK, Baker GB.
    Psychopharmacology (Berl); 1999 Mar 09; 142(3):280-8. PubMed ID: 10208320
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Recent studies on the MAO inhibitor phenelzine and its possible metabolites.
    McKenna KF, Baker GB, Coutts RT, Rauw G, Mozayani A, Danielson TJ.
    J Neural Transm Suppl; 1990 Mar 09; 32():113-8. PubMed ID: 1982447
    [Abstract] [Full Text] [Related]

  • 14. Overview of the Neuroprotective Effects of the MAO-Inhibiting Antidepressant Phenelzine.
    Matveychuk D, MacKenzie EM, Kumpula D, Song MS, Holt A, Kar S, Todd KG, Wood PL, Baker GB.
    Cell Mol Neurobiol; 2022 Jan 09; 42(1):225-242. PubMed ID: 33839994
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Chronic administration of the antidepressant-antipanic drug phenelzine and its N-acetylated analogue: effects on monoamine oxidase, biogenic amines, and alpha 2-adrenoreceptor function.
    McKenna KF, Baker GB, Coutts RT, Greenshaw AJ.
    J Pharm Sci; 1992 Aug 09; 81(8):832-5. PubMed ID: 1383493
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The antidepressant phenelzine enhances memory in the double Y-maze and increases GABA levels in the hippocampus and frontal cortex of rats.
    Simpson SM, Hickey AJ, Baker GB, Reynolds JN, Beninger RJ.
    Pharmacol Biochem Behav; 2012 Jul 09; 102(1):109-17. PubMed ID: 22503968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.